Literature DB >> 4513544

Myophosphorylase deficiency (McArdle's disease) in two interrelated families.

P Cochrane, R R Hughes, P H Buxton, R A Yorke.   

Abstract

The clinical and laboratory findings are presented of three patients (two affected sisters and their male cousin) with myophosphorylase deficiency in two interrelated families. Nine unaffected relatives were also investigated. Although the three patients demonstrated the characteristic features of the disease, their unaffected relatives showed no clear evidence of a heterozygous state. The genetic findings support the hypothesis that the disease is inherited as a rare autosomal recessive. A possible sex-limited mode of inheritance is discussed.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4513544      PMCID: PMC1083557          DOI: 10.1136/jnnp.36.2.217

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  17 in total

1.  A CASE OF MCARDLE'S SYNDROME WITH A POSITIVE FAMILY HISTORY.

Authors:  T D HOCKADAY; J A DOWNEY; R F MOTTRAM
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-06       Impact factor: 10.154

2.  MCARDLE'S DISEASE. HEREDITARY MYOPATHY DUE TO ABSENCE OF MUSCLE PHOSPHORYLASE.

Authors:  L P ROWLAND; S FAHN; D L SCHOTLAND
Journal:  Arch Neurol       Date:  1963-10

3.  MCARDLE'S DISEASE PRESENTING AS CONVULSION AND RHABDOMYOLYSIS.

Authors:  S E SALMON; C E TURNER
Journal:  Am J Med       Date:  1965-07       Impact factor: 4.965

4.  A metabolic myopathy due to absence of muscle phosphorylase.

Authors:  C M PEARSON; D G RIMER; W F MOMMAERTS
Journal:  Am J Med       Date:  1961-04       Impact factor: 4.965

5.  Chronic progressive myopathy with myoglobinuria: demonstration of a glycogenolytic defect in the muscle.

Authors:  R SCHMID; R MAHLER
Journal:  J Clin Invest       Date:  1959-11       Impact factor: 14.808

6.  The relationship of epinephrine and glucagon to liver phosphorylase. I. Liver phosphorylase; preparation and properties.

Authors:  E W SUTHERLAND; W D WOSILAIT
Journal:  J Biol Chem       Date:  1956-01       Impact factor: 5.157

7.  A FUNCTIONAL DISORDER OF MUSCLE ASSOCIATED WITH THE ABSENCE OF PHOSPHORYLASE.

Authors:  W F Mommaerts; B Illingworth; C M Pearson; R J Guillory; K Seraydarian
Journal:  Proc Natl Acad Sci U S A       Date:  1959-06       Impact factor: 11.205

8.  Effect of fenfluramine on blood-lipids in man.

Authors:  G L Pawan
Journal:  Lancet       Date:  1969-03-08       Impact factor: 79.321

9.  Histopathology of McArdle's disease in a family.

Authors:  P Bale; J F Hammett; F C Neale
Journal:  J Pathol Bacteriol       Date:  1967-10

10.  The clinical diagnosis of McArdle's disease. Identification of another family with deficiency of muscle phosphorylase.

Authors:  L P Rowland; R E Lovelace; D L Schotland; S Araki; P Carmel
Journal:  Neurology       Date:  1966-01       Impact factor: 9.910

View more
  2 in total

1.  McArdle's disease heterozygotes. Metabolic adaptation assessed using 31P-nuclear magnetic resonance.

Authors:  R T Bogusky; R G Taylor; L J Anderson; K L Angelos; J S Lieberman; D A Walsh
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

2.  Normal pregnancy and successful delivery in myophosphorylase deficiency (McArdle's disease).

Authors:  P Cochrane; B Alderman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-04       Impact factor: 10.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.